文献速递牙体牙髓病

曲马多与地塞米松黏膜下注射对牙髓炎根管治疗后疼痛的影响

The effect of pretreatment submucosal injections of tramadol and dexamethasone on post-endodontic pain in mandibular molar teeth with symptomatic irreversible pulpitis: a randomized controlled clinical trial.
PubMed 文献 · Int Endod J · 2019-11-28

这项随机对照双盲试验纳入90例下颌磨牙症状性不可逆牙髓炎患者,比较黏膜下注射曲马多、地塞米松与生理盐水对单次根管治疗后疼痛的影响。结果显示两种药物均能减轻治疗后疼痛,地塞米松在最初12小时内镇痛效果优于曲马多。

要点

  • 预处理黏膜下注射地塞米松或曲马多可减轻症状性不可逆牙髓炎单次根管治疗后的疼痛。
  • 地塞米松在治疗后12小时内的镇痛效果优于曲马多。
  • 两组药物在6小时和48小时疼痛强度均显著低于对照组。

核心结论

  • 预处理黏膜下注射地塞米松和曲马多均显著减轻症状性不可逆牙髓炎患者单次根管治疗后的疼痛。
  • 地塞米松在最初12小时内的疼痛缓解效果优于曲马多。

研究设计与样本

  • 随机对照双盲临床试验,纳入90例下颌第一或第二磨牙症状性不可逆牙髓炎患者,随机分为三组(n=30):生理盐水对照组、曲马多组(100 mg 2 mL-1)和地塞米松组(8 mg 2 mL-1)。
  • 局部麻醉后、治疗前于下颌磨牙邻近颊黏膜沟行黏膜下注射,所有组均行常规单次根管治疗。
  • 治疗后6、12、24、48和72小时采用Heft-Parker视觉模拟量表(0-170 mm)评估疼痛。
  • 统计分析采用单因素方差分析或Kruskal-Wallis H检验,组间两两比较采用Student t检验或Mann-Whitney U检验,显著性阈值P<0.0167。

主要发现

  • 在6小时和48小时时间点,地塞米松组和曲马多组的疼痛强度均显著低于对照组(P<0.0167)。
  • 在12小时结束时,地塞米松组的疼痛水平显著低于其他组(P<0.0167)。

关键数值与推荐

  • 曲马多单次剂量为100 mg 2 mL-1,地塞米松单次剂量为8 mg 2 mL-1,对照组给予生理盐水。
  • 疼痛评估采用Heft-Parker视觉模拟量表(0-170 mm),评估时间点为6、12、24、48和72小时。
  • 组间比较显著性阈值设定为P<0.0167。

临床怎么用

  • 对下颌磨牙症状性不可逆牙髓炎行单次根管治疗前,可考虑黏膜下注射地塞米松或曲马多以减轻术后疼痛。
  • 若关注术后最初12小时的镇痛效果,地塞米松可能优于曲马多。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To establish the effects of submucosal single doses of two medicines on postoperative pain after root canal treatment in mandibular molar teeth with symptomatic irreversible pulpitis. METHODOLOGY: In this randomized controlled, double-blind clinical trial, 90 patients with the diagnosis of symptomatic irreversible pulpitis in their mandibular first or second molars were included and randomly divided into three groups (n = 30): a control group that received normal saline and two experimental groups that received a single dose of either tramadol (100 mg 2 mL-1 ) or dexamethasone (8 mg 2 mL-1 ). After local anaesthesia and before treatment, submucosal injections were administered into the mucobuccal fold adjacent to the mandibular molars, and a routine single-visit root canal treatment procedure was performed in all groups. After the root canal treatments, the patients were asked to score their pain level using the Heft-Parker visual analogue scale (0-170 mm) at 6, 12, 24, 48 and 72 h. The experimental groups were compared using one-way anova or Kruskal-Wallis H-test. The groups that were significantly different were compared pairwise using Student's t-test or the Mann-Whitney U-test. The findings were expressed as the mean ± standard deviation or median (min-max). The categorical variables were tested using the chi-square test or Fisher's exact chi-square test, and the results were expressed as counts and percentages. RESULTS: At the 6-h and 48-h time intervals, the intensity of pain was significantly less in both the dexamethasone and tramadol groups than in the control group (P < 0.0167). At the end of 12 h, the pain level in the dexamethasone group was significantly less compared to the other groups (P < 0.0167). CONCLUSIONS: Pretreatment submucosal dexamethasone and tramadol injections significantly diminished post-treatment endodontic pain of patients with symptomatic irreversible pulpitis following single-visit root canal treatment. However, dexamethasone was more effective than tramadol in pain reduction in the first 12 h.

来源:Int Endod J,查看原文。版权归原作者所有。

引用

  1. Aksoy F, Ege B. The effect of pretreatment submucosal injections of tramadol and dexamethasone on post-endodontic pain in mandibular molar teeth with symptomatic irreversible pulpitis: a randomized controlled clinical trial. Int Endod J. 2019. PMID: 31702056. doi:10.1111/iej.13246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。